Raffles FinTech Secures Four Strategic Mandates to Up Clients' IPO Market Cap Via Trade Finance Revolving Credit

Executive Summary

• Raffles FinTech Limited (RFT), a wholly‑owned subsidiary of Raffles Financial Group Ltd., has secured four strategic advisory contracts with Regen Healthcare, CAPA Medical Facility, SAFA (Sustainable Aviation Fuel Asia) Pte Ltd., and Silica Material Tech.
• The engagements cover supply‑chain finance technology, revolving credit arrangement, restructuring, corporate finance, and IPO advisory services to be delivered over the next 24 months.
• These contracts represent a significant resumption of RFT’s business activity and provide non‑dilutive financing solutions that could materially enhance the valuation and growth trajectory of each client prior to their planned public listings.

Key Details

• Contract Scope: Each client has mandated RFT to (i) advise on supply‑chain finance technology, (ii) arrange trade‑finance revolving credit facilities, and (iii) provide IPO advisory services.
• Clients & Industries:
• Regen Healthcare – fast‑growing ASEAN/China healthcare provider; focus on procurement‑to‑payment funding.
• CAPA Medical Facility – Singapore‑based medical/surgical facility undergoing corporate restructuring and expansion in ASEAN/China.
• SAFA (Sustainable Aviation Fuel Asia) – asset‑light network for collection/pre‑treatment of used cooking oil, targeting the US$25 bn SAF market by 2030.
• Silica Material Tech – producer of ultra‑high‑purity silicon sand for semiconductor and new‑energy sectors; holds 14 core patents.
• Timeline: Advisory and financing services to be executed within a 24‑month horizon from contract signing (July 2025 onward).
• Strategic Rationale: RFT’s non‑dilutive capital model aims to fund client growth via revolving credit, thereby increasing enterprise value ahead of IPOs.
• Executive Commentary: Prof. Kevin Lou (Chief Consulting Officer, RFT) highlighted the “strong validation of RFT's innovative approach to non‑dilutive financing and corporate advisory.” CEOs of each client echoed confidence that the mandates will enable liquidity optimization, accelerated growth, and enhanced market valuations.

Notable Quotes

• Prof. Kevin Lou: “RFT resumed business from July 2025, and we are delighted to secure four strategic clients… This is a strong validation of RFT's innovative approach to non‑dilutive financing and corporate advisory.”
• Regen Healthcare CEO, Li Jing: “Partnering with RFT … is a necessary step to fund our accelerated growth and transition into a publicly listed company.”
• CAPA Medical Facility CEO, Ricky Yan: “The RFT mandate is pivotal for our next phase of development… enabling us to successfully execute our global fund‑raising plan.”
• SAFA CEO, Tony Li: “This partnership is crucial for unlocking the capital efficiency needed to achieve that valuation.”
• Silica Material Tech CEO, Mr. Zhao CJ: “The collaboration with RFT is expected to accelerate the company's growth trajectory, positioning it as a key player in the silica global supply chain.”